A Collierville man has been awarded more than $140 million in a lawsuit against the makers of a testosterone drug that he says caused him to have a heart attack.
A federal court jury in Chicago handed down the verdict in favor of Jeffrey Konrad on Thursday after several weeks of testimony in which his lawyers argued that Chicago-based AbbVie Inc. misrepresented the risks of its drug known as AndroGel.
